Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Bayer and Bioton Discussing Insulin Distribution Deal for China

publication date: Mar 24, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Bayer AG is working on a deal to distribute insulin products produced by Bioton S.A. in China, according to China Knowledge. Bioton is a Polish biotechnology company. Janusz Guy, CEO of Bioton, would say only that the company is choosing a candidate for business cooperation from a number of different companies, a list that includes Bayer. More details..

Stock Symbols: (Frankfurt: BAY) (ASX: SIE)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...